Word: ayerst
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...same time, physicians, including thousands of general practitioners, are being chatted up by sales agents for Wyeth-Ayerst Laboratories, a division of American Home Products, which is marketing Redux. And in October, according to doctors and industry analysts, the company will begin a widespread advertising campaign to promote the drug directly to the public. (The company begs to differ: it claims it is planning only to "educate" the public about obesity.) Just three months after the introduction of Redux, doctors are writing 85,000 prescriptions a week. Says David Crossen, an analyst for Montgomery Securities in San Francisco: "What...
...1970s with a proposal that he purchase the U.S. rights to dexfenfluramine. Wurtman tested the drug, found it was indeed effective and agreed. The actual purchaser would be Interneuron Pharmaceuticals, a company co-founded by Wurtman to market discoveries by M.I.T. scientists. Interneuron subsequently licensed the drug to Wyeth-Ayerst for marketing...
That doesn't mean the FDA has declared Redux to be entirely safe. As a condition of approval, the agency is requiring Wyeth-Ayerst to do follow-up testing. "We're concerned," says Bilstad, "that there could be subtle effects that you can pick up only in a clinical study." Among the possibilities: troubling changes in mood, like depression and aggressiveness, that might derive from a serotonin deficit...
Despite the FDA's tacit green light, drugmakers are not likely to apply for formal approval. Wyeth-Ayerst, the largest U.S. producer of oral contraceptives, has no plans to market such pills or even include emergency contraceptive instructions on its current products. The real problem, rather than any political fallout, says Wyeth spokeswoman Audrey Ashby, is the risk of getting bogged down in costly product-liability suits...
...diet pill that would erase those fleshy bulges. They may never get their wish, but they may be getting closer. Last week the U.S. Food and Drug Administration approved a new antiobesity drug called dexfenfluramine that will be sold in America perhaps as early as June by Wyeth-Ayerst under the brand name Redux. It is the first diet drug approved for use in the U.S. in the past 23 years and represents a new generation of smarter, more subtle antiobesity medications...